What intravenous fluid (IVF) should be used for post-acute tubular necrosis (ATN) diuresis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intravenous Fluid Management for Post-ATN Diuresis

Balanced crystalloid solutions should be used as the first-line intravenous fluid for post-acute tubular necrosis diuresis to minimize the risk of hyperchloremic metabolic acidosis and optimize renal recovery. 1

Rationale for Balanced Crystalloid Solutions

When managing post-ATN diuresis, the choice of intravenous fluid is critical for several reasons:

  1. Physiological Composition: Balanced crystalloids (such as Ringer's lactate or Plasma-Lyte) have electrolyte compositions closer to extracellular fluid, with lower chloride content than normal saline.

  2. Acid-Base Balance: Balanced solutions are consistently associated with better acid-base balance compared to 0.9% NaCl, which can cause hyperchloremic metabolic acidosis 1.

  3. Renal Outcomes: Evidence suggests that balanced crystalloids result in lower rates of acute kidney injury compared to saline, which is particularly important in the recovering kidney after ATN 2.

Evidence Supporting This Recommendation

Recent evidence demonstrates that balanced crystalloids offer advantages over normal saline:

  • A large randomized trial in critically ill adults found that balanced crystalloids resulted in a lower rate of major adverse kidney events (death, new renal-replacement therapy, or persistent renal dysfunction) compared to saline (14.3% vs 15.4%, P=0.04) 2.

  • The potentially deleterious effects on renal function from high-volume chloride-rich solutions should orient treatment choices toward balanced solutions 1.

  • Balanced solutions help prevent hyperchloremic metabolic acidosis, which is particularly important in patients recovering from ATN 3.

Monitoring During Post-ATN Diuresis

During the diuretic phase of ATN recovery, close monitoring is essential:

  • Fluid Balance: Carefully track intake and output to match fluid losses
  • Electrolytes: Monitor serum sodium, potassium, chloride, and bicarbonate at least daily
  • Renal Function: Follow creatinine and BUN trends
  • Acid-Base Status: Monitor for metabolic acidosis, especially if using normal saline

Special Considerations

  1. Hypernatremia Risk: In cases of significant free water losses during diuresis, isotonic fluids may be insufficient to prevent hypernatremia. Consider supplementing with hypotonic fluids if serum sodium rises above 144 mEq/L 1.

  2. Potassium Supplementation: Post-ATN diuresis often leads to potassium wasting. Consider adding potassium to IV fluids based on serum levels.

  3. Volume Status: Tailor fluid rate to match urine output while avoiding volume overload or depletion.

Pitfalls to Avoid

  • Excessive Fluid Administration: Overzealous fluid replacement can lead to volume overload and pulmonary edema.

  • Inadequate Replacement: Insufficient fluid replacement can lead to volume depletion and may impair renal recovery.

  • Unbalanced Solutions: Using large volumes of 0.9% saline can cause hyperchloremic metabolic acidosis and potentially worsen renal outcomes 1, 3.

  • Hypertonic Solutions: 3% or 7.5% hypertonic saline solutions are not recommended for routine fluid therapy in this setting 1.

By using balanced crystalloid solutions for post-ATN diuresis, you can optimize electrolyte balance, minimize acid-base disturbances, and potentially improve renal recovery outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Balanced Crystalloids versus Saline in Critically Ill Adults.

The New England journal of medicine, 2018

Research

Balanced Crystalloid Solutions.

American journal of respiratory and critical care medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.